Cartesian Therapeutics, Inc. - Common Stock (NQ:RNAC)
7.210
+0.270
(+3.89%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 368,372 |
| Open | 6.930 |
| Bid (Size) | 6.600 (100) |
| Ask (Size) | 7.200 (200) |
| Prev. Close | 6.940 |
| Today's Range | 6.880 - 7.260 |
| 52wk Range | 5.980 - 20.12 |
| Shares Outstanding | 115,079,292 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 27, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
September 19, 2025
Cartesian (RNAC) Q2 Revenue Drops 99% ↗
August 07, 2025
Frequently Asked Questions
Is Cartesian Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cartesian Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cartesian Therapeutics, Inc. - Common Stock trade on?
Cartesian Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cartesian Therapeutics, Inc. - Common Stock?
The ticker symbol for Cartesian Therapeutics, Inc. - Common Stock is RNAC on the Nasdaq Stock Market
What is the current price of Cartesian Therapeutics, Inc. - Common Stock?
The current price of Cartesian Therapeutics, Inc. - Common Stock is 7.210
When was Cartesian Therapeutics, Inc. - Common Stock last traded?
The last trade of Cartesian Therapeutics, Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of Cartesian Therapeutics, Inc. - Common Stock?
The market capitalization of Cartesian Therapeutics, Inc. - Common Stock is 829.72M
How many shares of Cartesian Therapeutics, Inc. - Common Stock are outstanding?
Cartesian Therapeutics, Inc. - Common Stock has 830M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube